EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer.
Chan AM, Aguirre B, Liu L, Mah V, Balko JM, Tsui J, Wadehra NP, Moatamed NA, Khoshchehreh M, Dillard CM, Kiyohara M, Elshimali Y, Chang HR, Marquez-Garban D, Hamilton N, Pietras RJ, Gordon LK, Wadehra M.
Chan AM, et al. Among authors: chang hr.
Cancers (Basel). 2024 Apr 12;16(8):1481. doi: 10.3390/cancers16081481.
Cancers (Basel). 2024.
PMID: 38672563
Free PMC article.